Melanoma and other Skin Tumours

Access all ESMO scientific and educational resources on this topic
Recent medwireNews and resources from conferences are for ESMO Members only.

Tumour Knowledge Portal

Preselected recommended educational resources on Melanoma.

 

Stéphane Champiat reports the findings presented at AACR 2018, in particular the results from a phase III study of pembrolizumab in adjuvant treatment of melanoma, and results from a phase Ib study of Toll-like receptor 9 (TLR-9) agonist in melanoma resistant to anti-PD-1 therapy.

Clinical Practice Guidelines

Factsheets on Biomarkers

07 Dec 2017 PD-L1 in Cancer Hendrik-Tobias Arkenau
01 Aug 2015 NRAS in Melanoma Nicola Normanno
01 Aug 2015 BRAF in Melanoma Nicola Normanno